Etofenamate

Basic Information

Item Value
DrugBank ID DB08984
Evidence Level L5 (Computational Prediction)
Number of Predicted Indications 100

Predicted Indications (TxGNN)

The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.

# Indication Source
1 spondyloarthropathy, susceptibility to KG + DL
2 ankylosing spondylitis KG + DL
3 rheumatoid vasculitis KG + DL
4 hypermobility of coccyx KG + DL
5 acromesomelic dysplasia, Hunter-Thompson type KG + DL
6 brachyolmia-amelogenesis imperfecta syndrome KG + DL
7 pseudoachondroplasia KG + DL
8 myosclerosis KG + DL
9 polyarticular juvenile rheumatoid arthritis KG + DL
10 Kummell disease KG + DL
11 inflammatory spondylopathy KG + DL
12 brachyolmia KG + DL
13 juvenile idiopathic arthritis KG + DL
14 rheumatoid nodulosis KG + DL
15 rheumatoid factor-positive polyarticular juvenile idiopathic arthritis KG + DL
16 juvenile chronic polyarthritis KG + DL
17 juvenile arthritis due to defect in LACC1 KG + DL
18 vertebral disease KG + DL
19 WHIM syndrome KG + DL
20 rheumatoid arthritis KG + DL
21 avascular necrosis of femoral head, primary KG + DL
22 brachydactyly-syndactyly syndrome KG + DL
23 mendelian susceptibility to mycobacterial diseases due to complete IL12B deficiency KG + DL
24 colobomatous microphthalmia-rhizomelic dysplasia syndrome KG + DL
25 spondyloarthropathy KG + DL
26 Stickler syndrome, type I, nonsyndromic ocular KG + DL
27 Czech dysplasia, metatarsal type KG + DL
28 platyspondylic dysplasia, Torrance type KG + DL
29 spondylometaphyseal dysplasia, Schmidt type KG + DL
30 mild spondyloepiphyseal dysplasia due to COL2A1 mutation with early-onset osteoarthritis KG + DL
31 spondyloepimetaphyseal dysplasia, Handigodu type KG + DL
32 spondyloperipheral dysplasia-short ulna syndrome KG + DL
33 synovitis (disease) KG + DL
34 megaepiphyseal dwarfism KG + DL
35 ankylosis (disease) KG + DL
36 spondyloepiphyseal dysplasia, Reardon type KG + DL
37 brachydactylous dwarfism, Mseleni type KG + DL
38 progressive pseudorheumatoid arthropathy of childhood KG + DL
39 spondylo-megaepiphyseal-metaphyseal dysplasia KG + DL
40 bursitis KG + DL
41 tenosynovitis KG + DL
42 spondyloepimetaphyseal dysplasia, Genevieve type KG + DL
43 spondyloepimetaphyseal dysplasia-abnormal dentition syndrome KG + DL
44 vertebral joint disease KG + DL
45 combined immunodeficiency due to moesin deficiency KG + DL
46 fibroma KG + DL
47 transient arthropathy KG + DL
48 shoulder impingement syndrome KG + DL
49 ganglion or cyst of synovium/tendon/bursa KG + DL
50 Behcet syndrome arthropathy KG + DL

(Showing top 50 of 100 predictions)

Disclaimer

These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.


← Back to Drug Search


Copyright © 2026 藥提醒科技有限公司 (yao.care). 本報告僅供研究參考,不構成醫療建議。

This site uses Just the Docs, a documentation theme for Jekyll.